It is uncertain whether uterine leiomyosarcoma arises de novo or in preexisting leiomyoma. Leiomyoma-like areas can be seen associated with uterine leiomyosarcoma, raising the possibility of precursor ...
The focus of this study was to explore copy number alterations, MED12 mutational status, and FH-deletions in diagnostically challenging smooth muscle tumors with special emphasis on leiomyoma with ...
NEW YORK (MedscapeWire) Apr 05 — Transcervical biopsy has a 100% negative predictive value in ruling out uterine sarcoma, based on a study in the March 15 issue of Cancer. "The clinical differential ...
Please provide your email address to receive an email when new articles are posted on . The risk for unexpected uterine sarcoma in women undergoing myomectomy for presumed benign leiomyoma varied ...
Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine The preoperative distinction between uterine leiomyoma (LM) and leiomyosarcoma (LMS) is ...
A group of 49 physicians disagrees with recent restrictions placed by the US Food and Drug Administration (FDA) on the use of power morcellators during minimally invasive surgery in women with uterine ...
GDF15 and OPN show promise in differentiating uterine sarcoma from leiomyoma, outperforming traditional markers like LDH and CA125. GDF15 serves as an independent prognostic factor for ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A 55-year-old female with history of ...
Here are the top 5 soft tissue sarcoma articles of 2025: ...
Doctors are arguing that the U.S. Food and Drug Administration relied on a flawed analysis when it ruled last year that noncancerous growths in the uterus could no longer be removed using mechanical ...
Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine The preoperative distinction between uterine leiomyoma (LM) and leiomyosarcoma (LMS) is ...